User profiles for Doug Coyle
Doug CoyleProfessor, University of Ottawa Verified email at uottawa.ca Cited by 21302 |
[HTML][HTML] Cost-effectiveness of new oral anticoagulants compared with warfarin in preventing stroke and other cardiovascular events in patients with atrial fibrillation
… Wells is the nominated principal investigator and Doug Coyle, Chris Cameron, and Karen
Lee are coinvestigators on the team grant. The publication of study results was not contingent …
Lee are coinvestigators on the team grant. The publication of study results was not contingent …
The influence of experiential knowledge on prenatal screening and testing decisions
Minimal research focuses on the process of decision making in the context of prenatal
screening and testing. This paper outlines an important contextual influence on these decisions. …
screening and testing. This paper outlines an important contextual influence on these decisions. …
Home telehealth for chronic disease management: a systematic review and an analysis of economic evaluations
Objectives: The research objectives were two-fold: first, to systematically review the literature
on the cost-effectiveness of home telehealth for chronic diseases, and second to develop a …
on the cost-effectiveness of home telehealth for chronic diseases, and second to develop a …
[HTML][HTML] An evaluation framework for funding drugs for rare diseases
…, M Sabharwal, A Gadhok, H Stevenson, D Coyle - Value in Health, 2012 - Elsevier
Objectives For rare diseases it may be difficult to generate data from randomized trials to
support funding of a drug. Enzyme replacement therapies for diseases of inherited metabolic …
support funding of a drug. Enzyme replacement therapies for diseases of inherited metabolic …
[BOOK][B] Application of operations research to funding decisions for treatments with rare disease
In this chapter, the focus is on the application of decision analytic tools to assist in reimbursement
decisions related to drugs for rare diseases. Focus is on the evaluative framework …
decisions related to drugs for rare diseases. Focus is on the evaluative framework …
The societal unit cost of allogenic red blood cells and red blood cell transfusion in Canada
BACKGROUND: There is a dearth of information about the cost of allogenic red blood cells (RBCs)
and RBC transfusion in Canada in the aftermath of the Canadian blood system …
and RBC transfusion in Canada in the aftermath of the Canadian blood system …
Cost-effectiveness of self-monitoring of blood glucose in patients with type 2 diabetes mellitus managed without insulin
Background: The benefits of self-monitoring blood glucose levels are unclear in patients
with type 2 diabetes mellitus who do not use insulin, but there are considerable costs. We …
with type 2 diabetes mellitus who do not use insulin, but there are considerable costs. We …
Family caregiver burden: results of a longitudinal study of breast cancer patients and their principal caregivers
E Grunfeld, D Coyle, T Whelan, J Clinch, L Reyno… - Cmaj, 2004 - Can Med Assoc
Background: The vital role played by family caregivers in supporting dying cancer patients
is well recognized, but the burden and economic impact on caregivers is poorly understood. …
is well recognized, but the burden and economic impact on caregivers is poorly understood. …
[PDF][PDF] Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care
Purpose Most women with breast cancer are diagnosed at an early stage and more than 80%
will be long-term survivors. Routine follow-up marks the transition from intensive treatment …
will be long-term survivors. Routine follow-up marks the transition from intensive treatment …
Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis
Background Serious infections are a major concern for patients considering treatments for
rheumatoid arthritis. Evidence is inconsistent as to whether biological drugs are associated …
rheumatoid arthritis. Evidence is inconsistent as to whether biological drugs are associated …